selenomethylselenocysteine has been researched along with Colorectal Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badmaev, V; Ho, CT; Lo, CY; Pan, MH; Tsai, ML; Wang, FZ; Wang, YJ; Wu, JC | 1 |
| Bhattacharya, A; Cao, S; Durrani, FA; Faber, E; Repasky, EA; Rustum, YM; Sen, A; Seshadri, M; Tóth, K | 1 |
| Cheng, WH; Lartey, FM; Qi, Y; Schoene, NW | 1 |
3 other study(ies) available for selenomethylselenocysteine and Colorectal Cancer
| Article | Year |
|---|---|
Se-Allylselenocysteine induces autophagy by modulating the AMPK/mTOR signaling pathway and epigenetic regulation of PCDH17 in human colorectal adenocarcinoma cells.
Topics: Adenocarcinoma; AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Autophagy; Cadherins; Colorectal Neoplasms; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Mice, Inbred BALB C; Promoter Regions, Genetic; Selenocysteine; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2015 |
Inhibition of colon cancer growth by methylselenocysteine-induced angiogenic chemomodulation is influenced by histologic characteristics of the tumor.
Topics: Animals; Antibiotics, Antineoplastic; Anticarcinogenic Agents; Cell Differentiation; Colon; Colorectal Neoplasms; Cysteine; Doxorubicin; Drug Delivery Systems; Drug Resistance, Neoplasm; Female; Humans; Hypoxia; Immunoenzyme Techniques; Magnetic Resonance Imaging; Mice; Mice, Nude; Neovascularization, Pathologic; Organoselenium Compounds; Selenocysteine; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2009 |
Selenium compounds activate ATM-dependent DNA damage response via the mismatch repair protein hMLH1 in colorectal cancer cells.
Topics: Acetylcysteine; Adaptor Proteins, Signal Transducing; Adenosine Triphosphatases; Anticarcinogenic Agents; Antioxidants; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line, Tumor; Colorectal Neoplasms; Cysteine; DNA Breaks; DNA Mismatch Repair; DNA Repair Enzymes; DNA-Binding Proteins; Drug Resistance, Neoplasm; Guanosine; Humans; Mismatch Repair Endonuclease PMS2; Morpholines; MutL Protein Homolog 1; Nuclear Proteins; Organoselenium Compounds; Piperidines; Protein Serine-Threonine Kinases; Pyrones; Reactive Oxygen Species; Selenocysteine; Sodium Selenite; Tumor Suppressor Proteins | 2010 |